Aristocrat Leisure: Interim result 2017
Aristocrat keeps releasing popular games, and keeps going from strength to strength.
Thorn Group: Result 2017
Not much went right for Thorn Group in 2017, but that's reflected in its share price.
Tatts wins Victorian lottery licence
Tatts has successfully won a 10-year contract to operate lotteries in Victoria.
Adacel adds up
After decades in the doldrums, Adacel is flying high after a profit spurt. But is it a good investment?
Why Buffett loves airlines, but you should still avoid Qantas
Qantas's loyalty program is one of its biggest money-spinners, but it's not enough to outweigh the risks.
Connecting with NextDC
This owner of data centres boasts high quality economics and a sticky, growing customer base. The accounts don't reflect that at all.
Gentrack: Interim result 2017
The addition of new customers and a large uptick in services revenue led to an impressive result for this billing software maker.
Westpac reduces stake in BTIM
The bank has offloaded another 19% of its holding in BT Investment Management.
Ansell sells condom division
This glove maker's most pun-laden operations have been sold to a Chinese healthcare company at a great price.
OFX Group: Result 2017
The international payments group has reported a reassuring result despite a sharp fall in profits, but we'll take more convincing.
F&P Healthcare: Result 2017
Higher litigation costs from a dispute with ResMed didn't take the shine off this impressive result.
DuluxGroup: Interim result 2017
Less cyclical than it appears, this paint manufacturer produced another solid result in the first half.
Hope fades for Sirtex Medical
Another string of failed clinical trials removes the potential for blockbuster growth.
CYBG: Interim result 2017
Despite Brexit and economic uncertainty, CYBG's results continue to improve since being spun off from NAB.
Cease Coverage on MAH
Macmahon has been a mildly successful recommendation. It's time to end coverage.
Cochlear's secret sauce
An industry-leading research budget isn't enough for Cochlear to do well - it must also time the market.
Ceasing coverage on Metcash
Despite evidence that management is making a difference, there's little sign Metcash's long-term decline can be arrested.
Monash IVF chief to exit
This IVF provider is on the lookout for a new chief executive after a surprise resignation.
Macquarie Group: Result 2017
This investment bank's share price has increased 56% in just over a year, but we see little reason to increase our price guide.
News Corp's valuable properties
You can almost ignore News Corp's old media assets these days. The online real estate division has more than justified management's confidence.
A speed bump Transurban can't avoid
Falling interest rates have been rocket fuel for this toll road operator's earnings and share price. But there's a dark side.
Westpac: Interim result 2017
Westpac's result, like those of its peers, shows investors in the big banks will likely see little growth in coming years.
Budget hits banks with levy
The government has announced a levy on the big banks to raise $6.2bn over four years.
Call 1300 880 160
Start a chat
Schedule a call
